As the number of patients identified to date is small and several relapses have been reported, it is important to evaluate the actual outcomes of patients in this group, which appear to be worse than those of patients with ETV6/RUNX1-rearranged ALL. Here, RUNX1 is linked to acute lymphoblastic leukemia.